1. Home
  2. DRVN vs ADPT Comparison

DRVN vs ADPT Comparison

Compare DRVN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$12.72

Market Cap

2.0B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$13.53

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRVN
ADPT
Founded
1972
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
DRVN
ADPT
Price
$12.72
$13.53
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$19.00
$17.78
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
59.82
63.89
EPS
0.69
N/A
Revenue
$2,339,588,000.00
$276,976,000.00
Revenue This Year
N/A
$3.98
Revenue Next Year
$1.53
$22.72
P/E Ratio
$18.22
N/A
Revenue Growth
1.54
54.77
52 Week Low
$9.80
$7.21
52 Week High
$19.74
$20.76

Technical Indicators

Market Signals
Indicator
DRVN
ADPT
Relative Strength Index (RSI) 51.35 44.44
Support Level $11.71 $12.22
Resistance Level $13.54 $15.38
Average True Range (ATR) 0.60 0.74
MACD -0.02 -0.00
Stochastic Oscillator 58.04 41.94

Price Performance

Historical Comparison
DRVN
ADPT

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: